Silvia Scarabelli joined the Wyss Center in May 2021 as Regulatory & Clinical Affairs Engineer. She supports the implementation of regulatory and clinical processes involved in the development of the implantable neurosensing and neuromodulation medical devices of the Wyss Center.

Previously, Silvia worked as a Clinical, Regulatory and Quality Affairs consultant for the MedTech industry, contributing to the compilation and submission of clinical investigation and technical dossiers to achieve EU and US market access. Prior to her experience as a consultant, Silvia worked as a Scientific Project Manager for the major Swiss national initiative in neuroscience, being exposed to projects in neuroscience, neuroinformatic and high-performance computing.

Silvia holds a PhD in Chemistry and Chemical Engineering from the Ecole Polytechnique Fédérale de Lausanne (EPFL). During her PhD studies, Silvia acquired extensive experience in experimental research in chemistry and molecular biology, with a particular focus on the cellular and biochemical assays related to the development of drug candidates.

In parallel to studies and work, Silvia has completed a Certificate of Advanced Studies (CAS) in Personalized Molecular Oncology from the University Hospital of Basel, as well as a CAS in Management of Pharma, Biotech and MedTech from the EPFL. Silvia also holds a certification in GCP and Research Ethics, recognized by Swissethics and Swissmedic. She is a Certified Associate in Project Management (CAPM)®.